PRESS RELEASE published on 05/03/2023 at 12:30, 3 years 3 months ago Empower Clinics Advances Research and Clinical Trials Division with The Signing of Another Experienced Principal Investigator
PRESS RELEASE published on 04/25/2023 at 12:30, 3 years 4 months ago Empower Clinics Accelerates Growth of Research and Clinical Trials Division with Signing of Two Additional Principal Investigators at First Site in Dallas, Texas
PRESS RELEASE published on 04/20/2023 at 12:30, 3 years 4 months ago Empower Clinics Announces Official Launch of Mobile Technology & Communications Platform, PulseIR Powered by Fobi
PRESS RELEASE published on 04/17/2023 at 12:30, 3 years 4 months ago Empower Clinics Signs Agreement To Conduct Research and Clinical Trials with Dallas, TX Based Medical Center - And Major Milestone With Signing Of Research Services Agreement With First Principal Investigator
PRESS RELEASE published on 03/21/2023 at 11:00, 3 years 5 months ago Empower Clinics Announces Exploration of Strategic Alternatives
PRESS RELEASE published on 03/20/2023 at 08:00, 3 years 5 months ago Empower Clinics Cancels Previously Announced Private Placement
PRESS RELEASE published on 03/07/2023 at 13:00, 3 years 5 months ago Empower Clinics Advances Partnership to Launch US Clinical Trial Management Services with Formation of Delaware Based Company and Identification of Principal Investigators
PRESS RELEASE published on 03/01/2023 at 01:20, 3 years 5 months ago CORRECTION: Empower Clinics Reports Q4 2022 Results
PRESS RELEASE published on 02/28/2023 at 23:00, 3 years 5 months ago Empower Clinics Reports Q4 2022 Results
PRESS RELEASE published on 02/27/2023 at 23:40, 3 years 5 months ago CORRECTION: Empower Clinics Announces FOBI Partnership To Elevate Investor Relations With Digital, Mobile and Personalized Engagement
Published on 08/27/2026 at 00:05, 29 minutes ago Kidoz Reports Record Q2 2026 Revenue, up 37%, as H1 Revenue Reaches US$6.28 Million (CAD$8.66 Million)
Published on 08/26/2026 at 23:00, 1 hour 34 minutes ago Datametrex Announces Transition to Semi-Annual Financial Reporting
Published on 08/26/2026 at 22:30, 2 hours 4 minutes ago AI/ML Innovations Inc. Closes First Tranche of Private Placement
Published on 08/26/2026 at 22:30, 2 hours 4 minutes ago Blueberries Medical Announces Closing of C$1.1 Million Non-Brokered Private Placement
Published on 08/26/2026 at 21:15, 3 hours 19 minutes ago Announces Private Placement of Convertible Promissory Notes
Published on 08/26/2026 at 23:05, 1 hour 28 minutes ago Biosidus expands biologics manufacturing capacity and strengthens global supply capabilities for agalsidase beta
Published on 08/26/2026 at 18:44, 5 hours 49 minutes ago AUSTRIACARD HOLDINGS AG: Press Release H1 2026 Financial Results
Published on 08/26/2026 at 18:40, 5 hours 53 minutes ago MBC GROUP REVEALS MBC GAMES STUDIO WITH DEBUT TITLE UNVEILING AT GAMESCOM
Published on 08/26/2026 at 18:30, 6 hours 4 minutes ago Heidelberg Pharma AG and Huadong Medicine Receive NMPA Approval for Clinical Trial of HDP-101 Combination Therapy in China
Published on 08/26/2026 at 18:00, 6 hours 34 minutes ago MHM Corporate: reduces the nominal value of its shares to €0.011
Published on 08/26/2026 at 18:02, 6 hours 32 minutes ago Altareit: Altarea press release regarding the Primonial matter
Published on 08/26/2026 at 18:02, 6 hours 32 minutes ago Altareit : Communiqué de presse d’Altarea relatif au dossier Primonial
Published on 08/26/2026 at 18:00, 6 hours 34 minutes ago Altarea: Comprehensive settlement agreement reached, ending the dispute between Altarea and the shareholders of the Praemia group (formerly Primonial group)
Published on 08/26/2026 at 18:00, 6 hours 34 minutes ago Altarea : Conclusion d’un accord global mettant fin au litige entre Altarea et les actionnaires du groupe Praemia (ex-groupe Primonial)
Published on 08/26/2026 at 18:00, 6 hours 34 minutes ago KLARSEN : lance Dimea, sa nouvelle activité e-commerce dédiée aux compléments alimentaires
